Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settingsYan Chen, Minhua Hu, Yingying Lin et al.|International Journal of Clinical Oncology|2010Cited by 55
Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based StudyJunying Guo, Yan Chen, Zhaolei Cui et al.|Pathology & Oncology Research|2020Cited by 10